{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:16:19Z","timestamp":1740176179623,"version":"3.37.3"},"reference-count":18,"publisher":"Central Research Institute for Epidemiology","issue":"6","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["virusjour.crie.ru"],"crossmark-restriction":false},"short-container-title":["Problems of Virology"],"abstract":"<jats:p>Introduction. The urgent problem of modern medicine is the fight against acute respiratory viral infections (ARVI). To combat ARVI, drugs of wide antiviral potency are needed, as well as immunomodulating drugs. Such antiviral and immunomodulatory effects has sodium deoxyribonucleate (DNA-Na) and its complex with iron (DNA-Na-Fe) developed on the basis of double-stranded DNA of natural origin.\r\nAim of the study: To assess antiviral and virucidal activity of DNA-Na and DNA-Na-Fe against viruses of different kingdoms and families.\r\nMaterials and methods. Antiviral and virucidal activity of DNA-Na and DNA-Na-Fe was assessed in cell cultures infected with viruses.\r\nResults and discussion. DNA-Na and DNA-Na-Fe had antiviral activity against adenovirus at concentrations of 2501000 mcg\/ml. Antiviral effect of both drugs was not detected in case of poliovirus. DNA-Na and DNA-Na-Fe had antiviral activity against coronavirus in all administration schemes. EC50 for DNA-Na ~ 2500 mcg\/ml, for DNA-Na-Fe ~ 1000 mcg\/ml. In cells treated with DNA-Na-Fe, secretion of following proinflammatory cytokines was detected: Interleukin (IL) 1, IL-2, IL-6, IL-18, interferon- (IFN-), IFN-, as well as anti-inflammatory cytokines: IL-4, IL-10, antagonist of IL-1 receptor. Evidently, DNA-Na and DNA-Na-Fe have antiviral effect, but mechanism of action does not seem to be associated with specific effect on viral replication. Presence of virucidal activity of drugs against representatives of Coronaviridae, Adenoviridae, Picornaviridae, Retroviridae, Herpesviridae in vitro test in range of 1.03.0 lg TCID50 was identified.\r\nConclusion. Presence of simultaneous antiviral and virucidal activity of DNA-Na and DNA-Na-Fe against adeno- and coronaviruses shows their prospects for prevention and treatment of ARVI.<\/jats:p>","DOI":"10.36233\/0507-4088-148","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T16:15:40Z","timestamp":1675786540000},"page":"506-515","update-policy":"https:\/\/doi.org\/10.36233\/0372-9311-crossmark","source":"Crossref","is-referenced-by-count":2,"title":["Antiviral and virucidal activity of sodium deoxyribonucleate and its complex with iron against viruses of different kingdoms and families"],"prefix":"10.36233","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5757-5671","authenticated-orcid":false,"given":"Dmitry N.","family":"Nosik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-8578","authenticated-orcid":false,"given":"Lyudmila B.","family":"Kalnina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9351-6433","authenticated-orcid":false,"given":"Olga A.","family":"Lobach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5379-2406","authenticated-orcid":false,"given":"Marina S.","family":"Chataeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1551-718X","authenticated-orcid":false,"given":"Elena V.","family":"Berezhnaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9295-8379","authenticated-orcid":false,"given":"Marina S.","family":"Bochkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3693-6081","authenticated-orcid":false,"given":"Irina A.","family":"Kiseleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3709-770X","authenticated-orcid":false,"given":"Lyudmila M.","family":"Selimova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1943-6536","authenticated-orcid":false,"given":"Nikolai N.","family":"Nosik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22004","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"ref1","unstructured":"L\u2019vov D.K., ed. Guidance to Virology: Viruses and Viral Infections of Humans and Animals [Rukovodstvo po virusologii: Virusy i virusnye infektsii cheloveka i zhivotnykh]. Moscow: MIA; 2013. (in Russian)"},{"key":"ref2","unstructured":"Temporary guidelines. Prevention, diagnosis, and treatment of novel coronavirus infection (COVID-19). Version 15; 2022. Available at: https:\/\/static-0.minzdrav.gov.ru\/system\/attachments\/attaches\/000\/059\/392\/original\/\u0412\u041c\u0420_COVID-19_V15.pdf (in Russian)"},{"key":"ref3","unstructured":"Nosik D.N., Kaplina E.N. Ferrovir. Experience of Application in Experimental and Medical Practice [Ferrovir. Opyt primeneniya v eksperimental\u2019noy i lechebnoy praktike]. Moscow: Nauchnaya kniga; 2005. (in Russian)"},{"key":"ref4","unstructured":"Nosik D.N., Nosik N.N., Kaplina E.N., Kalnina L.B., Kiseleva I.A., Kondrashina N.G., et al. Activity of \u00abFerrovir\u00bb preparation towards RNA and DNA viruses. Voprosy virusologii. 2002; 47(3): 21\u20133. (in Russian)"},{"key":"ref5","unstructured":"Besednova N.N., Makarenkova I.D., Fedyanina L.N., Avdeeva Zh.I., Kryzhanovskiy S.P., Kuznetsova T.A., et al. Prokaryotic and eukaryotic DNA in prevention and treatment of infectious diseases. Antibiotiki i khimioterapiya. 2018; 63(5-6): 52\u201367. (in Russian)"},{"key":"ref6","unstructured":"Mironov A.N., Bunatyan N.D. Guidelines for Conducting Preclinical Studies of Medicinal Products [Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv]. Moscow; 2012. (in Russian)"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Mosmann T. Rapid Colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983; 65(1-2): 55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","DOI":"10.1016\/0022-1759(83)90303-4"},{"key":"ref8","unstructured":"Nosik D.N., Nosik N.N. Fight against viruses. Disinfection [Bor\u2019ba s virusami. Dezinfektsiya]. Moscow: MIA; 2018. (In Russian)"},{"key":"ref9","unstructured":"Guidelines R 4.2.3676-20. Methods of laboratory research and testing of disinfectants to evaluate their effectiveness and security. Moscow; 2020. (in Russian)"},{"key":"ref10","unstructured":"Handbook of COVID-19 Prevention and Treatment. The First Affiliated Hospital, Zhejlang University School of Medicine; 2020. Available at: https:\/\/globalce.org\/downloads\/Handbook_of_COVID_19_Prevention_en_Mobile.pdf"},{"key":"ref11","unstructured":"Nosik D., Kaplina E., Nosik N., Kalnina L., Tsutsumi R., Miura Y., et al. A Fe3+\/DNA Complex induces an anti-human immunodeficiency virus factor(s) in CD4+ lymphocyte cell lines. Acta Virol. 1999; 43(1): 25\u201330."},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Harandi A.M., Eriksson K., Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection. J. Virol. 2003; 77(2): 953\u201362. https:\/\/doi.org\/10.1128\/jvi.77.2.953-962.2003","DOI":"10.1128\/JVI.77.2.953-962.2003"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. J. 2004; 5(10): 987\u201395. https:\/\/doi.org\/10.1038\/ni1112","DOI":"10.1038\/ni1112"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Kumagai Y., Takeuchi O., Akira S. Pathogen recognition by innate receptors. J. Infect. Chemother. 2008; 14(2): 86\u201392. https:\/\/doi.org\/10.1007\/s10156-008-0596-1","DOI":"10.1007\/s10156-008-0596-1"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Sauter M.M., Gauger J.J., Brandt C.R. Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps. Antiviral. Res. 2014; 109: 83\u201396. https:\/\/doi.org\/10.1016\/j.antiviral.2014.06.015","DOI":"10.1016\/j.antiviral.2014.06.015"},{"key":"ref16","unstructured":"Selimova L.M., Kalnina L.B., Kaplina E.N., Nosik D.N. The effect of Ferrovir on to expression of surface markers of activation by cells neoplastic line MT-4. Klinicheskaya laboratornaya diagnostika. 2017; 62(6): 355\u20139. https:\/\/doi.org\/10.18821\/0869-2084-2017-62-6-355-359 (in Russian)"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Kalnina L.B., Selimova L.M., Kaplina E.N., Nosik D.N. Expression of integrins \u03b21, \u03b14 and cell adhesion molecule ICAM-1 in the presence of sodium deoxyribonucleate with Ferrum complex (DNA-NA-FE) by MT-4 cells transformed by human T-lymphotropic virus type 1 (Retroviridae: orthoretrovirinae: deltaretrovirus: human T-lymphotropic virus type 1). Voprosy virusologii. 2021; 66(3): 227\u201332. https:\/\/doi.org\/10.36233\/0507-4088-57 (in Russian)","DOI":"10.36233\/0507-4088-57"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Shogan B., Kruse L., Mulamba G., Hu A., Coen D. Virucidal activity of a GT-Rich oligonucleotide against herpes simplex virus mediated by glycoprotein B. J. Virol. 2006; 80(10): 4740\u20137. https:\/\/doi.org\/10.1128\/jvi.80.10.4740-4747.2006","DOI":"10.1128\/JVI.80.10.4740-4747.2006"}],"container-title":["Problems of Virology"],"original-title":[],"link":[{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/667\/428","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/viewFile\/667\/428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T07:15:37Z","timestamp":1732086937000},"score":1,"resource":{"primary":{"URL":"https:\/\/virusjour.crie.ru\/jour\/article\/view\/667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":18,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,12,7]]}},"URL":"https:\/\/doi.org\/10.36233\/0507-4088-148","relation":{},"ISSN":["2411-2097","0507-4088"],"issn-type":[{"type":"electronic","value":"2411-2097"},{"type":"print","value":"0507-4088"}],"subject":[],"published":{"date-parts":[[2022,12,7]]}}}